Home » Newsletters » BioWorld Science

BioWorld Science

June 30, 2006

View Archived Issues

Dasatinib effective in imatinib-resistant leukemia

In vitro and in vivo characteristics of ofatumumab described

Oncolytic agents benefit from PPARgamma receptor-dependent and -independent dual mechanism

LC16m8 protects monkeys from monkeypox

Pooled data suggest heptavalent DTPw-HBV/Hib-MenAC vaccine is safe

Sosei and Mundipharma sign agreement for AD-923

ELI-154 completes second pilot phase I study

Phase II trial planned for atiprimod in advanced carcinoid cancer

Updated clinical data on tocilizumab as a treatment for arthritic disease

Phase II data report lack of efficacy for apratastat in RA

No safety concerns in phase II BPH study of NX-1207

Gantacurium chloride completes phase II study in endotracheal intubation

NVA-237 successfully completes phase IIb study in COPD

Mirtazapine results in obstructive sleep apnea do not warrant further studies

ASF-1075 studied for hand dermatitis in new study

XL-880 advances into phase II for papillary renal cell carcinoma

CMX-001 for treatment of smallpox infection cleared to begin phase I

Panzem awarded orphan drug designation for glioblastoma multiforme

NIAID to conduct antimicrobial evaluation of Viprovex

CoTherix inlicenses rights to oral and inhaled formulations of fasudil

Daytrana now available

VR-004 improves erectile performance with rapid onset of action

Revlimid approved for use in multiple myeloma

Novel antiinfective agents reported in recent patent literature

First launch for Acomplia

New agents for treating endocrine-related disorders patented

Melanocortin receptor agonist shows therapeutic potential in experimental arthritis

Phase II trial results of belimumab in systemic lupus erythematosus

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...